• VolitionRX held its annual shareholder meeting on July 17, 2026.
• Shareholders backed a charter amendment cutting authorized common shares to 150,000,000 from 325,000,000; the amendment was filed and took effect.
• Sadler, Gibb & Associates was ratified as independent auditor for the year ending Dec. 31, 2026.
• A 2026 Stock Incentive Plan was adopted.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VolitionRX Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-26-004421), on July 21, 2026, and is solely responsible for the information contained therein.